Gorzegno G - Search Results

1

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma.

Berruti A, Dogliotti L, Mosca A, Gorzegno G, Bollito E, Mari M, Tarabuzzi R, Poggio M, Torta M, Fontana D, Angeli A. Berruti A, et al. Among authors: gorzegno g. Ann Oncol. 2001;12 Suppl 2:S153-7. doi: 10.1093/annonc/12.suppl_2.s153. Ann Oncol. 2001. PMID: 11762344 Free article. Review.

2

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients.

Berruti A, Dogliotti L, Mosca A, Tarabuzzi R, Torta M, Mari M, Gorzegno G, Fontana D, Angeli A. Berruti A, et al. Among authors: gorzegno g. Prostate. 2001 May 15;47(3):205-11. doi: 10.1002/pros.1064. Prostate. 2001. PMID: 11351350

3

Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience.

Stivanello M, Berruti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A, Dogliotti L. Stivanello M, et al. Among authors: gorzegno g. Ann Oncol. 2001;12 Suppl 2:S73-7. doi: 10.1093/annonc/12.suppl_2.s73. Ann Oncol. 2001. PMID: 11762356 Free article.

4

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.

Tucci M, Mosca A, Lamanna G, Porpiglia F, Terzolo M, Vana F, Cracco C, Russo L, Gorzegno G, Tampellini M, Torta M, Reimondo G, Poggio M, Scarpa RM, Angeli A, Dogliotti L, Berruti A. Tucci M, et al. Among authors: gorzegno g. Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11. Prostate Cancer Prostatic Dis. 2009. PMID: 18332901 Free article.

5

Background to and management of treatment-related bone loss in prostate cancer.

Berruti A, Tucci M, Terrone C, Gorzegno G, Scarpa RM, Angeli A, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002. Drugs Aging. 2002. PMID: 12495366 Review.

6

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.

Berruti A, Fara E, Tucci M, Tarabuzzi R, Mosca A, Terrone C, Gorzegno G, Fasolis G, Tampellini M, Porpiglia F, De Stefanis M, Fontana D, Bertetto O, Dogliotti L; Gruppo Onco-Urologico Piemontese, Rete Oncologica Piemontese. Berruti A, et al. Among authors: gorzegno g. Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003. Urol Oncol. 2005. PMID: 15885575 Clinical Trial.

7

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients.

Berruti A, Mosca A, Bitossi R, Gorzegno G, Guercio S, Poggio M, Tampellini M, Porpiglia F, Ostellino O, Scarpa RM, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Anticancer Res. 2005 Nov-Dec;25(6C):4475-9. Anticancer Res. 2005. PMID: 16334129 Free article. Clinical Trial.

8

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease.

Berruti A, Tampellini M, Torta M, Buniva T, Gorzegno G, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Eur J Cancer. 1994;30A(14):2082-4. doi: 10.1016/0959-8049(94)00356-a. Eur J Cancer. 1994. PMID: 7857707

9

Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.

Berruti A, Borasio P, Roncari A, Gorzegno G, Mossetti C, Dogliotti L. Berruti A, et al. Among authors: gorzegno g. Ann Oncol. 1993 May;4(5):429-31. doi: 10.1093/oxfordjournals.annonc.a058527. Ann Oncol. 1993. PMID: 8353078 Free article.

10

Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment.

Berruti A, Dogliotti L, Osella G, Cerutti S, Reimondo G, Martino A, Gorzegno G, Catolla R, Angeli A. Berruti A, et al. Among authors: gorzegno g. Oncol Rep. 2000 Jul-Aug;7(4):777-81. doi: 10.3892/or.7.4.777. Oncol Rep. 2000. PMID: 10854543 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters